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Abstract
Background: Because inbred rat strains are widely used as laboratory models, knowledge of phenotypic and genetic
variations between strains will be useful to obtain insight into the relationship between different strains.
Methods and Results: We studied phenotypic traits: of each strain – BN/K, DA/K and WOKW –10 male rats were studied for
body weight and serum constituents at an age of 10 and 30 weeks. In addition, a total of 95 rats were studied for life
expectancy. At an age of 30 weeks, these male rats were killed by an overdose of anesthetic (Sevofluran, Abbott), and the
subcutaneous and visceral adipose tissue as well as bone tissue were removed to study the expression of 20 genes. There
were significant differences in body weight, serum lipids and leptin at an age of 30 weeks between strains. Regarding life
expectancy, BN rats lived longest (10726228d). The highest gene expression was found in bone of BN rats. In adipose
tissues, Nfkb1 is only expressed in subcutaneous adipocytes, and 5 genes, Col2a1, Mmp9, Tnfa, Ins1 and Cyp24a1, are not
expressed in adipocytes. The ranking BN=DA.WOKW was observed in only one gene in subcutaneous (Fto) and visceral
adipocytes (Col6a1). There were no significant differences in gene expression of one gene in subcutaneous adipocytes and
of 3 genes in visceral adipocytes. Comparing the gene expression in visceral and subcutaneous adipocytes, only one gene
showed a comparable behavior (Bmp1).
Conclusion: From these results, it can be concluded that obvious phenotypic differences are caused by genetic differences
between three rat strains, BN, DA and WOKW, as supported by gene expression studies in bone and adipose tissues.
Especially BN rats can be used to study the genetic basis of long life.
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Introduction
Despite the recent advances in human genetics, animal models
of human diseases remain attractive tools, not only to overcome
genetic complexity, but also to permit studies under stable
environmental conditions.
Rat inbred strains are widely used as laboratory models in
understanding basic biology and human health and disease.
Therefore, knowledge of phenotypic and genetic variation
between strains will be useful to obtain insight into the relationship
between different strains. This prompted us to study phenotypic
traits and the expression of selected genes in three inbred rat
strains to show the diversity of rat strains.
Brown Norway (BN) rats are slim, brown in color, have very soft
fur, are susceptible to respiratory inflammation, but resistant to the
induction of experimental allergic encephalomyelitis. They are
also susceptible to the development of mercury-induced autoim-
munity to renal basement membranes with the development of
membraneous glomerulonephritis. It was BN rats that were used
to encode the rat genome. Comparative studies showed that BN
rats are obviously different in genome compared to several other
inbred rat strains [1–3].
Dark agouti (DA) rats are agouti in colour, slim, and susceptible
to allergic encephalomyelitis, collagen induced arthritis and other
auto-immune diseases [4].
Wistar Ottawa Karlsburg RT1
u (WOKW) rats are white in
color (albino), powerfully built and develop facets of metabolic
syndrome with obesity, dyslipidemia, insulin resistance, hyper-
insulinemia, hyperleptinemia and glucose intolerance [5–10].
Because of this phenotypic diversity, the aim of our study was to
analyzed several phenotypic traits between BN, DA, and WOKW
rats at an age of 10 and 30 weeks, and additionally we studied the
life expectancy. Furthermore, these rat strains were also used for
gene expression studies, as variation in gene expression is heritable
and has been mapped to the genome in humans and model
organisms [11]. Hence, we studied the expression of 20 selected
genes in two organs, adipose tissue and bone; the genes selected
play a role in bone and lipid metabolism as well as in immunologic
reactions. These organs were chosen because DA and BN rats are
slim and WOKW rats are obese and the bone architecture is
different between DA and BN; BN rats tend to have fragile
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necks [12].
Results
As shown in Table 1, most differences were observed between
BN and WOKW as well as DA and WOKW at an age of 10
weeks. At an age of 30 weeks, these significant differences
remained in body weight, serum triglycerides, leptin and insulin.
The life expectancy was also significantly different: BN rats lived
longest (10726228d), followed by WOKW rats (8106158d), and
DA rats (523675d) had the shortest life expectancy.
The gene expression results in bone (A), subcutaneous (B) and
visceral adipocytes (C) are demonstrated in Figure 1. In bone, BN
rats showed the highest expression in 13 (Col1a1, Col2a1,Col6a3,-
Col18a1, Bmp1, Ppp3ca, Mmp9, Rnd3, Nfkb, Il10, Tnfa, Retn,
Cyp24a1) out of 20 genes studied at an age of 30 weeks. In 7
genes (Bmp3, Bmp4, Bglap, Vegfa, Fto, Ins1, Pltp), the expression of
BN rats was comparable to that of DA rats. It is obvious that the
relative gene expression is higher in BN rats by factors of 10
(Col6a3, Bglap, Nfkb1,Fto, Retn), 20 (Col2a1, Bmp4, Rnd3), 30
(Col18a1) or even 140 (Cyp24a1) and 400 (Tnfa). Similar to BN,
at an age of 30 weeks, a higher expression of Bmp3, Vegfa and Pltp is
observed in DA rats by factors of 100, 7 and 17, respectively.
Analyzing the gene expression in adipose tissues, Nfkb1 is only
expressed in subcutaneous adipocytes, whereas 5 genes, Col2a1,
Mmp9, Tnfa, Ins1 and Cyp24a1, are not expressed in adipocytes
but in bone. In subcutaneous adipocytes, 14 out of 15 genes are
significantly different, whereas in visceral adipocytes 11 out of
15 genes showed significant differences. In contrast to bone,
most genes in DA rats are more highly expressed than BN
genes in subcutaneous adipocytes (13/15) and half of them are
more highly expressed in visceral adipocytes (7/14). The
ranking BN=DA.WOKW was observed in only one gene
each in subcutaneous (Fto) and visceral adipocytes (Col6a1).
Comparable behavior of gene expression was seen in Col1a1 in
bone and subcutaneous adipocytes (BN.DA=WOKW) and in
Bmp1 in both adipose tissues (BN,DA.WOKW). Furthermore,
there were no significant differences in the expression of one
gene (Bmp4) in subcutaneous adipocytes and of 3 genes (Ppp3ca,
Fto and Pltp) in visceral adipocytes. There were also 2 genes
(Col1a1, Col18a1) which showed a significantly higher expression
in WOKW than in BN and DA rats in visceral adipocytes,
which was never seen in subcutaneous adipocytes and bone. If
the gene expression in visceral adipocytes is compared with
those in subcutaneous adipocytes, only one gene showed
a comparable expression (Bmp1).
In Table 2 correlations between fat ratio and gene expression in
subcutaneous and visceral adipocytes are summarized. The fat
ratio in BN rats correlated with gene expression of Bmp3
(r=0.892) and in DA rats with Fto expression (r=0.924) in
subcutaneous adipocytes. In WOKW rats, the fat ratio was
negatively correlated with Il10 (r=20.896) and Pltp (r=20.927)
in subcutaneous adipocytes and positively in Ppp3ca (0.914) and
Pltp (r=0.864) in visceral adipocytes.
Discussion
The aim the study was not only to show phenotypic differences
between different rat strains but also to look at the DNA level by
gene expression studies. The Phenotype of BN, DA and WOKW
rats showed clearly the diversity of strains. The greatest differences
were observed in serum triglycerides, which were significantly
different between BN, DA and WOKW rats at an age of 10 and
30 weeks, and in life expectancy. The lowest triglyceride values
were found in DA rats, followed by that of BN and finally WOKW
rats.
However, the fat ratio also deserves our interest. Comparing the
amount of subcutaneous and visceral fat it is obvious that the
amount is increasing with age which is pronounced in BN rats
where the amount increased more than 2 times in both,
subcutaneous and visceral fat. The lowest increase or better
a stagnation of visceral fat was observed in WOKW rats with age
(4.1 vs. 4.2). Also taking serum leptin produced by adipocytes into
consideration, the fat ratio remained similar in BN rats, but the
leptin levels dropped. In DA rats, the fat ratio dropped in favor of
visceral adipose tissue and serum leptin values increased. The
reverse was found in WOKW rats. The fat ratio increased in favor
of subcutaneous adipose tissue, and instead of decreasing, the
leptin values increased obviously. That means the behavior
Table 1. Phenotype of male BN, DA and WOKW rats at an age of 10 and 30 weeks (mean 6 SD).
Traits BN DA WOKW
P-values between strains at
age 10 and 30 weeks
Age (weeks) 10 30 10 30 10 30 BN vs.
DA
BN vs. WOKW DA vs.
WOKW
n=10 n=10 n=10 n=10 n=10 n=10 10 30 10 30 10 30
Body weight (g) 20367 303612 21666 299644 320615 532651 ,.05 n.s. ,.001 ,.001 ,.001 ,.001
Subcutaneous fat (g) 2.260.46 4.660.60 2.860.13 3.060.78 3.860.41 4.960.32 ,.001 ,.001 ,.001 n.s ,.001 ,.001
Visceral fat (g) 1.860.16 4.360.61 1.560.16 2.660.48 4.160.46 4.260.86 n.s. ,.001 ,.001 n.s ,.001 ,.001
Fat ratio# 1.260.3 1.160.1 1.960.1 1.260.1 0.960.1 1.260.3 ,.001 n.s. ,.001 n.s. ,.01 n.s.
Serum triglycerides (mmol/l) 1.360.3 1.560.1 0.7160.2 0.7860.2 3.560.4 6.160.5 ,.001 ,.001 ,.001 ,.001 ,.001 ,.001
Serum Cholesterol (mmol/l) 1.960.15 1.560.12 2.660.19 2.860.22 2.260.26 2.860.4 ,.001 ,.001 ,.01 ,.001 ,.001 n.s.
HDL-C (mmol/l) 1.360.07 1.160.2 0.860.01 0.960.02 0.760.03 0.860.05 ,.001 n.s. ,.001 n.s. ,.001 n.s.
Leptin (ng/ml) 2.860.9 2.260.8 2.860.7 4.361.1 5.862.1 9.462.2 n.s. ,.05 ,.001 ,.001 ,.001 ,.001
Insulin (ng/ml) 1.861.3 1.460.2 1.760.8* 1.860.8 3.260.9 5.662.0 n.s. n.s. ,.05 ,.001 ,.01 ,.001
Survival (days) 10726228 (n=30) 523675 (n=25) 8106158 (n=40) ,.001 ,.001 ,.001
#Amount of subcutaneous (s) divided by amount of visceral adipose tissue (v).
doi:10.1371/journal.pone.0038981.t001
Differences between DA, BN and WOKW Rats
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WOKW rats.
Obvious differences were also found in serum cholesterol, in
which the changes with age were interesting. From 10 to 30 weeks,
the values decreased in BN (1.9–1.5 mmol/l), remained similar in
DA (2.6–2.8 mmol/l) and increased in WOKW rats (2.2–
2.8 mmol/l). This behavior between strains is comparable with
those of serum insulin. Considering that a decrease in the total
cholesterol as well as the low-density lipoprotein cholesterol level
results in a reduction of the progression of vascular disease and of
coronary heart disease, the cholesterol reduction in BN rats should
result in a longer life which was found in BN rats [13,14].
In terms of life expectancy, BN rats survived more than 1000
days, followed by WOKW and then DA rats. The latter had the
lowest life expectancy, which was the half of BN rats. Given that
BN rats have such a high life expectancy, their health should be
excellent.
The behavior of some of these phenotypic traits should be
reflected in gene expression in subcutaneous and visceral
adipocytes.
The gene expression studies in adipose tissue of mice suggest
that genes associated with vascularization and tissue remodelling
are major regulatory points controlling differences in adipose tissue
expansion. Bmp3 and Fto belong to such genes showing a strong
association with increased adiposity [15]. That may explain the
high correlation between fat ratio and expression of Bmp3 in DA
and of Fto in BN rats. However, there were two different genes in
BN and DA rats, suggesting differences in the regulation of body
fat content.
In contrast to BN and DA rats, WOKW rats develop facets of
metabolic syndrome [5–10]. This can explain the fact that more
genes correlated with fat ratio in WOKW than in BN and DA. Pltp
correlates with fat ratio which is positively correlated in visceral
adipocytes and negatively in subcutaneous adipocytes. Consider-
ing the total values of fat the positively correlation in subcutaneous
tissue is associated with an increase of fat from 10 to 30 weeks of
age (3.8 vs. 4.9g) whereas in visceral fat the fat mass remained
comparable between 10 and 30 weeks (4.1 vs. 4.2g). As shown in
human studies PLTP mRNA levels in subcutaneous, but not in the
visceral, adipose tissue were positively related to the BMI of the
subjects. These results strongly suggest that visceral and sub-
cutaneous adipocytes may have different properties in the
production of bioactive molecules [16]. The protein encoded by
this gene is one of at least two lipid transfer proteins found in
plasma. The encoded protein transfers phospholipids from tri-
glyceride-rich lipoproteins to high density lipoprotein (HDL). This
protein is thought to be involved in cholesterol metabolism.
Furthermore, it has been suggested that PLTP might play a role in
the regulation of body fat content. The mRNA levels and the
activity of PLTP have been consistently associated with obesity
[17–21]. Therefore, it can be assumed that Pltp also modulates the
level of adiposity in WOKW rats. Additional studies in humans
and mice have shown that there is an association between PLTP
genetic variants and obesity-related phenotypes [22–25]. There-
fore, Pltp could be a candidate gene for obesity in WOKW rats.
Besides fat ratio, marked differences were especially observed in
life expectancy between BN, DA and WOKW rats. The longevity
gene candidates have generally fallen into inflammatory and
immune-related factors. The factors involved in the inflammatory
response deserve particular attention, since aging is known to be
accompanied by several changes in the immune system. The
adaptive immune branch, such as the various T-lymphocyte
subpopulations, shows considerable decline (‘‘immunosenes-
cence’’), while in contrast, the innate part of immunity displays
a two- to four-fold increase in the production of proinflammatory
cytokines and acute phase proteins (‘‘inflammaging’’) [26–30].
Therefore, successful aging devoid of co-morbidities depends on
a combination of well-balanced anti- and proinflammatory
responses or processes that are largely genetically modified. If
a gene’s expression is associated with survival, the relationship
should be positively (BN.WOKW.DA) or negatively
(BN,WOKW,DA) correlated. Analyzing gene expression in
bone and adipose tissue, only two genes can be found in bone
which support this idea: Tnfa and Rnd3.
TNFa is a pleiotropic proinflammatory cytokine expressed
primarily in stimulated monocytes/macrophages in response to
microbes, mitogens and other cytokines. Its functions are related to
antitumor activity, immune modulation and inflammatory host
Figure 1. Relative gene expression in bone (A), subcutaneous (B) and visceral (C) adipocytes of 30 weeks old males (mean 6 SEM). *
BN, DA and WOKW are significantly different at 1 ** or 0.1*** per cent level. + BN and DA are significantly different to WOKW at 1++ or 0.1+++per cent
level. 1 BN is significantly different to DA and WOKW at 1++ or 0.1+++per cent level. # BN is significantly different to WOKW at 1 ## or 0.1 ### per
cent level. $ BN is significantly different to DA at 1 $$ or 0.1 $$$ per cent level. & DA is significantly different to WOKW at 1 && or 0.1 &&& per cent
level.
doi:10.1371/journal.pone.0038981.g001
Table 2. Significant correlations between fat ratio and gene expression in subcutaneous (Sub) and visceral (Vis) adipocytes of BN,
DA and WOKW rats.
Strains Genes Sub Vis
DA Bmp3 bone morphogenic protein3 0.892
P=0.017
BN Fto fat mass and obesity associated 0.924
P=0.025
WOKW Il10 interleukin10 20.896
P=0.016
Pltp phospholipid transfer protein 20.927
P=0.008
0.864
P=0.026
Ppp3ca protein phosphatase 3, catalytic subunit, alpha isoform 0.914
P=0.011
doi:10.1371/journal.pone.0038981.t002
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diseases [31]. Based on these facts, the high expression in bone of
BN rats may indicate that proinflammatory cytokines are also
highly expressed in other organs and thus cause the long life
expectancy of BN rats. That is not more a speculation because we
analysed the expression of Tnfa in blood and liver in addition to
bone. In blood the relative Tnfa expression was increased by factor
100 in BN (687661145) in comparison to DA (50612) and
WOKW (74624). The differences in the liver were present too but
no so pronounced as in blood. The relative expression of Tnfa in
liver of BN rats (90611) was significantly higher compared with
DA (2263) and WOKW rats (1565). Now one could assume that
high Tnfa expression is related to life expectation. This assumption
is supported by findings of Napolioni et al. 2011. They have shown
that a combination of functional SNPs within TNFa and another
gene can influence life expectancy in a gender-specific manner.
Especially males lived longer than females [31].
Rnd3 is also of interest in this context. Rnd proteins are
a subfamily of Rho GTPases involved in the control of actin
cytoskeleton dynamics and other cell functions, such as motility,
proliferation and survival. Furthermore, the high expression of
Rnd3 in bone of BN rats may suggest a general phenomenon. Rnd3
KO mice have shown that it is essential for postnatal development,
since Rnd3 null mice die shortly after birth and show important
structural defects, such as the absence of the common peroneal
nerve, and notable motor and behavioral deficits. Therefore, this
gene may support longer life expectancy [32].
In conclusion, obvious phenotypic differences are caused by
genetic differences between the three rat strains, BN, DA and
WOKW, as supported by gene expression studies in bone and
adipose tissues. Especially BN rats can be used to study the genetic
basis of long life.
Materials and Methods
Animals
BN/K, DA/K and WOKW rats were bred and kept in our own
animal facility. All rats were specified pathogen free and had free
access to food (Ssniff V132, R-Z, Soest, Germany: raw protein
21.2%; raw fat 3.8%; crude fiber 4.4%; metabolizable energy 13.3
MJ/kg) and acidulated water. Rats were kept in Macrolon type III
cages (Ehret, Emmendingen, Germany) in groups of two and
maintained on a 12:12-h light/dark cycle (5 AM/5 PM).
Phenotype Characterization
Ten male BN, DA and WOKW rats were studied for body
weight and serum parameters (triglycerides, total cholesterol, HDL
cholesterol, insulin, leptin) at an age of 10 and 30 weeks. At an age
of 30 weeks, these male rats were killed by an overdose of
anesthetic (Sevofluran, Abbott), and the subcutaneous and visceral
adipose tissue and bone tissue were removed. Adipose tissue was
weighed and the relative fat ratio was determined by dividing the
weight of subcutaneous fat by that of visceral fat.
Blood samples were obtained between 7 and 9 am. Serum leptin
and serum insulin were determined using a radioimmunoassay kit
(Rat Leptin RIA Kit; Linco Research, St Charles, MO, USA) or
ELISA (Rat Insulin ELISA; Mercodia, Uppsala, Sweden). Total
serum cholesterol, HDL cholesterol and serum triglycerides were
analyzed by lipid electrophoresis.
In addition, other BN (n=30), DA (n=25) and WOKW rats
(n=40) were observed up to their natural death to determine the
life expectancy of each strain. However, if the rats appeared
moribund before natural death, they were killed with an overdose
of anesthetic (Sevofluran, Abbott).
Ethics Statement
The animal research protocol was in accordance with the
current version of the German Law on the Protection of Animals.
The experimentation was approved by the Animal Ethical
Committee of Greifswald and by the appropriate local authority
(Landesveterina ¨r- und Lebensmitteluntersuchungsamt, Rostock,
Germany).
RNA Isolation and cDNA Synthesis
Bone and adipose tissue from 6 of 10 males at an age of 30
weeks were used for gene expression studies. At the time of
euthanasia, the tibial bone was harvested from the proximal
metaphysis to the tibiofibular junction, excluding all cartilaginous
and soft tissue. The tibias were snap frozen in liquid nitrogen and
pulverized. Total RNA was extracted with Trizol (Qiagen, Hilden,
Germany). After death, subcutaneous and visceral adipose tissue
was also removed. Adipocytes were isolated by collagenase (1 mg/
ml) digestion for 30 min. Total RNA of subcutaneous and visceral
adipocytes was isolated with RNeasy Mini Kit (Qiagen, Hilden,
Germany). Residual DNA was removed by DNase treatment
(RNase-Free DNase Set; Qiagen, Hilden, Germany) according to
the manufacturer’s instructions. A defined amount of purified
RNA (1.5 mg) from organ samples was transcribed in cDNA and
stored at 220uC until use, as detailed previously [9,33].
Real-time Quantitative PCR
Real-time PCR was performed using the ABI PRISM sequence
detection system 7000 (Perkin–Elmer Applied Biosystems, Foster
City, CA, USA) according to the manufacturer’s instructions,
using ABI PRISM 7000 SDS Software Version 1.1. Reactions
were performed with 12.5 ml SYBR-Green Master Mix (ABI), 0.4–
2.0 ml of each primer (50 ng/ml), 6 ml template (cDNA) or no
template (NTC), and RNase-free water was added to obtain a final
volume of 25 ml. The cycling conditions were as follows: 50uC for
2 min, initial denaturation at 95uC for 10 min, followed by 45
cycles of 95uC for 15 s, and 60uC for 1 min. Each quantitative
PCR was performed in duplicate. Target cDNA was amplified by
primer sets for collagen, type I, alpha 1 (Col1a1, Acc.-No.
NM_053304.1), collagen, type II, alpha 1 (Col2a1, Acc.-No.
NM_012929.1), procollagen, type VI, alpha 3 (Col6a3, Acc.-No.
NM_001109008.1), collagen, type XVIII, alpha 1 (Col18a1, Acc.-
No. XM_241632.5), bone morphogenetic protein 1 (Bmp1; Acc.-
No. NM_031323.1), bone morphogenetic protein 3 (Bmp3, Acc.-
No. NM_017105.1), bone morphogenetic protein 4 (Bmp4, Acc.-
No. NM_012827.2), bone gamma-carboxyglutamate (gla) protein
(Bglap, Acc.-No. NM_013414.1), protein phosphatase 3, catalytic
subunit, alpha isoform (Ppp3ca, Acc.-No. NM_017041.1), matrix
metallopeptidase 9 (Mmp9, Acc.-No. NM_031055.1), Rho family
GTPase 3 (Rnd3, Acc.-No. NM_001007641.1), nuclear factor of
kappa light polypeptide gene enhancer in B-cells 1(Nfkb1, Acc.-No.
XM_001075876.2), interleukin 10 (Il10, Acc.-No. NM_012854.2),
tumor necrosis factor alpha (Tnfa, Acc.-No. NM_012675.3),
vascular endothelial growth factor A (Vegfa, Acc.-No.
NM_001110336), fat mass and obesity associated gene (Fto,
Acc.-No. NM_001039713.1), Resistin (Retn, Acc.-No.
NM_144741.1), Insulin1 (Ins1, Acc.-No. NM_019129.3), phos-
pholipid transfer protein (Pltp, Acc.-No. NM_001168543.1), and
cytochrome P450, family 24, subfamily a, polypeptide 1 (Cyp24a1,
Acc.-No. NM_201635.2). The rat 18S rRNA gene served as the
endogenous reference gene. For each experimental sample, the
amounts of targets and endogenous reference (18S rRNA) were
determined from the calibration curve. The target amount was
then divided by the endogenous reference amount to obtain
a normalized target value.
Differences between DA, BN and WOKW Rats
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Results are expressed as means 6 SD (Table 1) or means 6
SEM (Figure 1). Differences were assessed by one-way analysis of
variance corrected by Bonferroni-Holm using the Statistical
Package for the Social Sciences (SPSS, Chicago, IL, USA).
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